Atherosclerosis as a disease of failed endogenous repair

Andrey G Zenovich1, Doris A Taylor

  • 1Center for Cardiovascular Repair, University of Minnesota, Minneapolis, MN 55455, USA.

Insights

Inflammation drives coronary artery disease (CAD). Stem/progenitor cells attempt vascular repair, but age and risk factors impair them, highlighting sex-based differences in CAD treatment strategies.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Immunology

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
  • Inflammation is a key pathological mechanism in CAD progression, from endothelial dysfunction to heart failure.
  • Atherosclerosis is increasingly recognized as a disease involving impaired endogenous vascular repair processes.

Purpose of the Study:

  • To explore the role of stem/progenitor cells in vascular repair within the context of CAD.
  • To investigate how aging and cardiovascular risk factors affect progenitor cell function.
  • To examine sex-based differences in progenitor cell capacity and their implications for CAD pathogenesis and treatment.

Main Methods:

  • Review of recent advances in stem/progenitor cell biology and their application in CAD.
  • Identification of key progenitor cell populations involved in vascular repair (e.g., endothelial progenitor cells [AC133+/CD34+], vascular progenitors [CD31+/CD45(low)], KDR+ cells).
  • Analysis of factors influencing progenitor cell efficacy, including age, risk factors, and sex.

Main Results:

  • Stem/progenitor cells are mobilized for vascular repair in CAD.
  • Age and cardiovascular risk factors significantly impair progenitor cell function, even before clinical CAD diagnosis.
  • Emerging evidence suggests sex-based differences in progenitor cell repair capacity may explain clinical CAD disparities between men and women.

Conclusions:

  • Enhancing endogenous vascular repair mechanisms by stem/progenitor cells offers a potential therapeutic avenue for CAD.
  • Understanding the impact of age, risk factors, and sex on progenitor cells is crucial for developing effective, personalized CAD treatments.
  • Quantifying cellular injury and repair processes is key to shifting the balance towards repair and preventing CAD progression.

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation01:38

Inflammation

Overview
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...